Quantification of nortriptyline in plasma by HPLC and fluorescence detection

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 878, Issue 9-10, 2010, Pages 841-844

  Almudever, Patricia ^a   Peris, José Esteban ^a   Garrigues, Teresa ^a   Diez, Octavio ^a   Melero, Ana ^a   Alós, Manuel ^b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b HOSPITAL GENERAL DE CASTELLÓN   (Spain)

Author keywords

Derivatization; Fmoc chloride; HPLC; Nortriptyline

Indexed keywords

CALIBRATION CURVES; CHLOROFORMATES; CONCENTRATION RANGES; DERIVATIZATION REACTION; DERIVATIZATIONS; FLUORESCENCE DETECTION; FMOC-CL; INTRAVENOUS ADMINISTRATION; ISOCRATIC; LIMIT OF DETECTION; LOWER LIMIT OF QUANTIFICATIONS; NORTRIPTYLINE; ONE STEP; PLASMA SAMPLES; RELATIVE STANDARD DEVIATIONS; REVERSED PHASE; ROOM TEMPERATURE; TIME INTERVAL;

CHLORINE COMPOUNDS; CHROMATOGRAPHIC ANALYSIS; CHROMATOGRAPHY; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PLASMAS; POLYMORPHISM;

HIGH PRESSURE LIQUID CHROMATOGRAPHY;

NORTRIPTYLINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DERIVATIZATION; DRUG BLOOD LEVEL; DRUG DETERMINATION; FLUORESCENCE ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIDEPRESSIVE AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; LIMIT OF DETECTION; NORTRIPTYLINE; RATS;

RATTUS;

EID: 77549083322     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2010.01.033     Document Type: Article

References (23)

1. Gillman P.K. Br. J. Pharmacol. 151 (2007) 737
2. Thase M.E. Dialogues Clin. Neurosci. 8 (2006) 217
3. Anczak J.D., and Nogler R.A. Clin. Med. Res. 1 (2003) 201
4. Hughes J.R., Stead L.F., and Lancaster T. Cochrane Database Syst. Rev. 1 (2007) Art. No.: CD00003
5. Mooney M.E., Reus V.I., Gorecki J., Hall S.M., Humfleet G.L., Muñoz R.F., and Delucchi K. Clin. Pharmacol. Ther. 83 (2008) 436
6. Queiroz R.H., Lanchote V.L., Bonato P.S., and de Carvalho D. Pharm. Acta Helv. 70 (1995) 181
7. Ghahramani P., and Lennard M.S. J. Chromatogr. B: Biomed. Appl. 685 (1996) 307
8. Theurillat R., and Thormann W. J. Pharm. Biomed. Anal. 18 (1998) 751
9. Tybring G., Nordin J., and Widén J. J. Chromatogr. B: Biomed. Sci. Appl. 716 (1998) 382
10. Olesen O.V., Plougmann P., and Linnet K.J. J. Chromatogr. B: Biomed. Sci. Appl. 746 (2000) 233
11. Oztunc A., Onal A., and Erturk S. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 774 (2002) 149
12. Frahnert C., Rao M.L., and Grasmäder K. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 794 (2003) 35
13. Bose D., Durgbanshi A., Martinavarro-Domínguez A., Capella-Peiró M.E., Carda-Broch S., Esteve-Romero J., and Gil-Agustí M. J. Pharmacol. Toxicol. Methods 52 (2005) 323
14. Alves C., Fernandes C., Dos Santos Neto A.J., Rodrigues J.C., Costa Queiroz M.E., and Lanças F.M. J. Chromatogr. Sci. 44 (2006) 340
15. Shinozuka T., Terada M., and Tanaka E. Forensic Sci. Int. 162 (2006) 108
16. Woźniakiewicz M., Wietecha-Posłuszny R., Garbacik A., and Kościelniak P. J. Chromatogr. A 1190 (2008) 52
17. Kirchherr H., and Kühn-Velten W.N. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 843 (2006) 100
18. Titier K., Castaing N., Le-Déodic M., Le-Bars D., Moore N., and Molimard M. J. Anal. Toxicol. 31 (2007) 200
19. Santos-Neto A.J., Bergquist J., Lanças F.M., and Sjöberg P.J. J. Chromatogr. A 1189 (2008) 514
20. Breaud A.R., Harlan R., Kozak M., and Clarke W. Clin. Biochem. 42 (2009) 1300
21. Torres-Molina F., Aristorena J.C., Garcia-Carbonell C., Granero L., Chesa-Jiménez J., Pla-Delfina J., and Peris-Ribera J.E. Pharm. Res. 9 (1992) 1587
22. Gjelstad A., Rasmussen K.E., and Pedersen-Bjergaard S. Anal. Bioanal. Chem. 393 (2009) 921
23. Richelson E. American Psychiatric Association Task Force on Treatments of Psychiatric Disorders. Treatments of Psychiatric Disorders vol. 3 (1989), American Psychiatric Association, Washington, DC pp. 1773-1786